SC-514
目录号: A12746
IκB/IKK 抑制剂
SC-514 是一种口服活性、ATP竞争性的 IKKβ抑制剂(IC50 = 3 - 12 μM),相较于其他28种激酶(包括JNK、p38、MK2和ERK)显示出超过10倍的选择性。
| Discription | SC-514 is an orally active, ATP-competitive IKKβ inhibitor (IC50 = 3 - 12 μM) that displays > 10-fold selectivity over 28 other kinases including JNK, p38, MK2 and ERK. | |||||
|---|---|---|---|---|---|---|
| Targets |
|
|||||
| Cell Research |
|
| 目录号 | A12746 |
|---|---|
| 分子式 | C9H8N2OS2 |
| 分子量 | 224.3 |
| CAS号 | 354812-17-2 |
| SMILES | C1=CSC=C1C2=CC(=C(S2)C(=O)N)N |
| 其他名称 | SC514, SC 514 |
| 储存条件 | Store lyophilized at -20ºC, keep desiccated. |
| In vitro (25°C) | DMSO | 41 mg/mL (182.79 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
| In vivo | 2% DMSO+30% PEG 300+2% Tween 80+ddH2O | 3 mg/mL | |
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 44.58 mL | 222.92 mL | 445.83 mL |
| 0.5 mM | 8.92 mL | 44.58 mL | 89.17 mL |
| 1 mM | 4.46 mL | 22.29 mL | 44.58 mL |
| 5 mM | 0.89 mL | 4.46 mL | 8.92 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2